Coronary artery disease. Atherosclerotic heart disease of native coronary artery
Conditions
Interventions
Intervention 1: Intervention group: receiving a standard diet containing olive oil as the main fat source + consuming three capsules of rice bran oil produced by Giltaz company and fucoxanthin produc
Sponsors
Rasht University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 70 Years
Inclusion criteria
Inclusion criteria: Age range 20 to 70 years Not using vitamin and mineral supplements, antioxidants, fiber supplements, omega-3 No history of kidney disease, no current alcohol consumption Coronary artery occlusion diagnosed by angiography by a cardiologist. No current consumption of alcoholic beverages
Exclusion criteria
Exclusion criteria: Changes in the patient's coronary disease treatment plan during the study Changing the type of drugs used, effective factors studied Creating any kind of dissatisfaction in the field of oil taste and...
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum lipid profile levels (triglycerides, total cholesterol, LDL-C and HDL-C). Timepoint: At the beginning of the study and 12 weeks later. Method of measurement: BT2000 device.;Fasting blood sugar. Timepoint: At the beginning of the study and 12 weeks later. Method of measurement: BT2000 device.;Serum insulin. Timepoint: At the beginning of the study and 12 weeks later. Method of measurement: BT2000 device.;Glycosylated hemoglobin. Timepoint: At the beginning of the study and 12 weeks later. Method of measurement: ELISA device.;Erythrocyte sedimentation rate. Timepoint: At the beginning of the study and 12 weeks later. Method of measurement: ELISA device.;Glutathione peroxidase activity. Timepoint: At the beginning of the study and 12 weeks later. Method of measurement: ELISA device.;Glutathione reductase activity. Timepoint: At the beginning of the study and 12 weeks later. Method of measurement: ELISA device.;Vitamin E. Timepoint: At the beginning of the study and 12 weeks later. Method of measurement: ELISA device.;HS - C-reactive protein. Timepoint: At the beginning of the study and 12 weeks later. Method of measurement: ELISA device. | — |
Secondary
| Measure | Time frame |
|---|---|
| Mean systolic and diastolic blood pressure. Timepoint: At the beginning of the study and 12 weeks later. Method of measurement: Pressure indicator.;Body mass index. Timepoint: At the beginning of the study and 12 weeks later. Method of measurement: Centimeter and scales. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMarjan Mahdavi Roshan
Rasht University of Medical Sciences
Outcome results
None listed